No Data
Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report
Baker Tilly and Definitive Healthcare Enhance Life Sciences Compliance
Leading advisory, tax and assurance firm Baker Tilly announces its collaboration with Definitive Healthcare to streamline fair market value (FMV) and key opinion leader (KOL) compliance procedures for life sciences
Definitive Healthcare Launches Redesigned Mobile App to Enhance Access to Healthcare Commercial Intelligence
FRAMINGHAM, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), a leader in healthcare commercial intelligence, today announced the launch of a redesigned mobile app for its popular View Suite
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare's Board of Directors (the
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
FRAMINGHAM, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced it has been named the 2024 Databricks Healthcare and